Abstract Number: PB1574
Meeting: ISTH 2020 Congress
Theme: Platelet Disorders and von Willebrand Disease » VWF and von Willebrand Factor Disorders - Clinical Conditions
Background: von Willebrand factor multimers (VWF:MM) methodologies are technically difficult, laborious, time consuming, non-standardized and results vary between labs. A first step towards standardization was made by introducing a semi‐automated VWF:MM assay by Sebia (Lisses, France). In addition to qualitative interpretation of multimer patterns, the Sebia PHORESIS software allows quantification of VWF:MM band patterns, thus the percentage of each molecular weight multimer fraction can be calculated. Due to lack of reference values for VWF:MM fractions, results interpretation can be challenging in some cases.
Aims: The aim of this study was to determine reference intervals for low molecular weight (LMW), intermediate molecular weight (IMW) and high molecular weight (HMW) multimers.
Methods: To collect a larger sample size an international cooperation was initiated. We analyzed data from 134 participants (51 males and 83 non-pregnant females) aged 17-69 years. Acceptance criteria: no history of hemorrhagic episodes; no usage of any medication for at least 10 days before blood collection; normal coagulation screening tests; normal VWF screening assay results; written consent provided.
Reference intervals (with 90% confidence intervals) were calculated using a robust method according to the CLSI C28-A3 standard. The study was performed according to the Declaration of Helsinki and was approved by national ethical committees.
Results: After outlier exclusion (n=3), done by Grubs double sided and Tukey methods, a total of 131 samples were analyzed statistically. Results were normally distributed. No significant differences were found between males and females. The proposed reference intervals for VWF:MM are presented in table 1.
Low Molecular Weight | Intermediate Molecular Weight | High Molecular Weight | |
Lower limit, % [90% CI] | 10.42 [9.94 – 10.95] | 22.55 [21.81 – 23.32] | 45.58 [44.54 – 46.71] |
Upper limit, % [90% CI] | 22.52 [21.52 – 23.51] | 37.57 [36.44 – 38.72] | 66.59 [65.10 – 68.02] |
[Table 1. Proposed reference intervals for VWF:MM]
Conclusions: Quantification of VWF:MM fractions, in addition to qualitative assessment of VWF:MM patterns, has potential value to aid in differential diagnosis of VWD sub-types. The reference values calculated in this study can be used in future research to establish clinical decision liimits.
To cite this abstract in AMA style:
Pikta M, Vasse M, Lejniece S, Smock KJ, Moser KA, Bautista H, Nouadje G, Banys V. Establishing Reference Intervals for von Willebrand Factor Multimers [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/establishing-reference-intervals-for-von-willebrand-factor-multimers/. Accessed October 2, 2023.« Back to ISTH 2020 Congress
ISTH Congress Abstracts - https://abstracts.isth.org/abstract/establishing-reference-intervals-for-von-willebrand-factor-multimers/